UNLV neuroscientists bolster the connection between Type II diabetes and Alzheimer's disease

NewsGuard 100/100 Score

A team of UNLV neuroscientists has strengthened the link between Type II diabetes and Alzheimer's disease.

In a study published in the September issue of the journal Communications Biology, researchers show that chronic hyperglycemia impairs working memory performance and alters fundamental aspects of working memory networks.

Diabetes is a major risk factor for developing Alzheimer's disease, but it is not clear why. We show that a central feature of diabetes, hyperglycemia, impairs neural activity in ways that are similar to what is observed in preclinical Alzheimer's disease models. This is the first evidence showing neural activity changes due to hyperglycemia overlap with what is observed in Alzheimer's systems."

James Hyman, study author and associate professor of psychology at UNLV

The research project is the continuation of a six-year collaboration between Hyman and coauthor Jefferson Kinney, chair and professor in UNLV's Department of Brain Health, to better understand why diabetes can elevate risk for Alzheimer's. The work is funded by a grant from the National Institute on Aging.

"As the number of Alzheimer's disease diagnoses rapidly rises and the incidence of diabetes and pre-diabetes has accelerated, it's crucial that we understand what connects these two disorders," Kinney said.

The researchers found that two parts of the brain that are central to forming and retrieving memories -; the hippocampus and the anterior cingulate cortex -; were over-connected, or hypersynchronized. When it came time to remember the correct information and complete a task, these two parts of the brain – which are affected early in Alzheimer's progression – were over-communicating with each other, sparking errors.

"We know synchrony is important for different parts of the brain to work together. But, we're finding more and more these days, that the key with neural synchrony is it has to happen at the right time, and it has to happen with control," Hyman said. "Sometimes, there's just too much 'talking' between certain areas and we think this leads to memory difficulties, among other things."

Hyman compares the situation to a CEO who hands over a majority of the company's business operations to their son, who then decides to upend previous communication structures and become the sole gatekeeper of information.

"The only communication the CEO has is with one person, as opposed to talking with all of the other people in the office," Hyman said. "It is possible that in Alzheimer's patients there's over-connection in certain areas where there should be flexibility. And in the models in our study, we're seeing evidence of that in real-time at these crucial moments to do the task."

This most recent finding not only provides novel information about brain activity in the hyperglycemia model, it also provides an additional important measure that can be used for continuing research.

"Our next step is to combine the biochemical markers and electrophysiology data to test specific mechanisms responsible and potential treatments," said Kinney. "This research will now be able to work towards understanding the risk as well as what may be able to be done to help."

Source:
Journal reference:

Wirt, R.A., et al. (2021) Altered theta rhythm and hippocampal-cortical interactions underlie working memory deficits in a hyperglycemia risk factor model of Alzheimer's disease. Communications Biology. doi.org/10.1038/s42003-021-02558-4.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Experimental monoclonal antibody prevents and reverses clinical type 1 diabetes in mice